Polyclonal anticardiolipin antibodies purified from pooled serum samples of patients with systemic lupus erythematosus were shown to have inhibitory effects on cultured normal rat brain astrocytes (RBA-1 cells). Anticardiolipin antibodies at concentrations from 50 to 200 g/ml inhibited the [3Hlthymidine incorporation of RBA-1 cells in a dose dependent manner after three days of culture. A kinetic study showed that anticardiolipin antibodies (100 [tg/ml) maximally inhibit the proliferation of RBA-1 cells (20-6 (5.1)% of the control value) after incubation for one day. In contrast, human y globulin (100 [tg/ml) had no effect on these cells. In the presence of anticardiolipin antibodies (100 pg/mI), the RBA-1 cells attached to the bottom of wells became spherical and the expression of glial fibrillary acidic protein in the cytoplasm was slightly reduced. Using 3,3'-dihexyloxacarbocyanine iodide as an indicator, anticardiolipin antibodies depolarised the membrane potential of RBA-1 cells after one day of culture. In addition, the percentage binding of RBA-1 cells with anticardiolipin antibodies was greater than with y globulin as determined by flow cytometric analysis. Immunofluorescence staining of brain tissue from BALB/c mice with anticardiolipin antibodies was noted in the corpus callosum, the cellular zone near the corpus callosum, and cells scattered in brain tissue. These results suggest that anticardiolipin antibodies have an inhibitory effect on brain cells and elicit thrombus formation in brain vessels, which plays a part in neuropsychiatric lupus.
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Neuropsychiatric manifestations are common in patients with systemic lupus erythematosus (SLE). More than 25% of these patients develop central nervous system disease in the first two years after the diagnosis of SLE. Microscopic studies of the brains of patients with SLE who died have emphasised the presence of widely scattered microinfarcts and a non-inflammatory vasculopathy. True vasculitis with inflammatory cells invading vessel walls and fibrinoid necrosis are rarely seen in the nervous system of patients with SLE, however.' 2 It is believed that autoantibodies reactive with the cell membrane in the circulation or cerebrospinal fluid, such as antilymphocyte,34 antineuronal,5 6 antineurofilament,7 8 or antiglycolipid9 antibodies parti-cipate in the development of central nervous system lupus:
Many reports""'9 have implied an association between anticardiolipin antibodies and various neurological diseases including central nervous system lupus, the myelopathy of lupoid sclerosis and Degos's disease, Guillain-Barre syndrome, migraine, chorea, and seizures. Using liposome or micelle purified anticardiolipin antibodies, Misra et al20 and Yu et al2' showed that anticardiolipin antibodies could react with and disturb the functions of lectin activated lymphocytes and neutrophil phagocytosis. As brain tissue contains a higher proportion of phospholipids than other organs, we speculate that anticardiolipin antibodies may have a biological effect on nerve tissue and may derange its function once the autoantibodies pass into the brain. In this study, anticardiolipin antibodies were purified from serum samples from patients with SLE and the effects of these antibodies on normal rat brain astrocytes and their binding capacity with brain tissue were investigated.
Materials and methods

PURIFICATION OF ANTICARDIOLIPIN ANTIBODIES WITH CARDIOLIPIN MICELLES
The purification of anticardiolipin antibodies followed the method described by Harris et al22 with some modifications.2'
SUBCULTURE OF NORMAL RAT BRAIN ASTROCYTES
The RBA-I cells were established by continuous passaging and enriching of cultures of the brain cells of three day old rats (JAR-2, F-51) for four years. The cells were cultured in 10% fetal bovine serum in RPMI 1640 without antibiotics. The RBA-1 cells were identified by the following properties: (a) no tumourigenicity when inoculated into nude mice; (b) 71-5% of the cells maintained diploid chromosomes in karyotype analysis; (c) the presence of glial fibrillary acidic protein in the cytoplasm detected by an immunochemical method; and (d) contact inhibition observed during long term culture.2325
[3H]THYMIDINE INCORPORATION OF RBA-1 CELLS RBA-1 cells (100 gIl; I x 105/ml) were placed in flat bottomed microwells in triplicate. Anticardiolipin antibodies (100 ,ui of 100, 200, and 400 ,ug/ml solutions) were added to the wells. In the control wells, 0-1 ml RPMI 1640 or the corresponding concentration of human y globulin (Cohn fraction II, Sigma Chemical, St Louis, MO, USA) was added instead of anticardiolipin antibodies. The mixture was incubated at 37°C in 5% carbon dioxide/95% air for 68 hours followed by four hours of pulsing with 18-5 kBq methyl [3H]thymidine (specific activity 2 5 x i05 MBq/mmol; NEN, Boston, MA, USA). The cells were harvested and the radioactivity measured by a ,B counter.
The membrane potential was measured by the method of Shapiro et al. 26 The indicator dye used was 3, 3'-dihexyloxacarbocyanine iodide (Eastman Kodak, Rochester, NY, USA). The RBA-1 cells (5 x 105/ml) were cultured and reacted with 100 [tg/ml anticardiolipin antibodies (or 100 [ig/ml of y globulin as control) in plastic petri dishes for one day before harvesting. The attached cells were collected by incubation with 0-125% trypsin-l mM EDTA in phosphate buffered saline solution (pH 7-2) for five minutes and the membrane potentials of these cells were estimated by EPICS C flow cytometry (Coulter Electronics, Hialeah, Miami, FL, USA) with excitation at 488 nm.
BINDING OF RBA-1 CELLS WITH ANTICARDIOLIPIN ANTIBODIES
RBA-1 (1 x 106 cells/0-1 ml) were reacted with 0-I ml anticardiolipin antibodies (400 ,ug/ml) or human y globulin (400 [ig/ml) in an ice bath for 30 minutes. After two washes with Hanks's balanced salt solution the cells were stained with FITC conjugated goat antihuman IgG in an ice bath for another 30 minutes. After washing with Isoton II (Coulter), the percentage and fluorescence intensity of RBA-1 cells were measured by EPICS C flow cytometry.
DETECTION OF GLIAL FIBRILLARY ACIDIC PROTEIN IN RBA-1 CELLS
The detection of glial fibrillary acidic protein was carried out by the indirect immunofluorescence method reported by Jou and Akimoto24 with some modifications. RBA-1 cells (I.5 X 105/ml) were cultured on coverslips and became attached after overnight incubation. Anticardiolipin antibodies, RPMI, or y globulin were then added to the individual cultures. After 18 hours incubation the cells were fixed in 70% ethanol (at 4°C) for one hour and coated with 0-5% bovine serum albumin to reduce the non-specific binding with proteins. The coverslips were then incubated in a moist chamber with mouse monoclonal antibodies to glial fibrillary acidic protein (1:200 dilution in phosphate buffered saline) (BioMakor, Israel) for one hour. After rinsing with phosphate buffered saline, the coverslips were stained with FITC conjugated goat antimouse IgG (Jackson Immunoresearch Laboratories, West Grove, PA, USA) at 1:20 dilution for 30 minutes and rinsed again with phosphate buffered saline. The cells were examined with a fluorescence microscope. After washing with phosphate buffered saline, FITC conjugated antihuman IgG (or FITC conjugated antimouse IgG for glial fibrillary acidic protein stain) was added and incubated for another 30 minutes. The slides were rinsed, mounted, and examined under a fluorescence microscope.
STATISTICAL ANALYSIS
The results are given as mean (SD) for the whole study. Statistic significance was analysed by the non-parametric Wilcoxon signed rank test.
Results
EFFECT OF ANTICARDIOLIPIN ANTIBODIES ON THE GROWTH OF RBA-1 CELLS
The proliferation of RBA-1 cells was evaluated by the incorporation of [3H]thymidine into the cells. Figure 1 shows that the inhibition of proliferation of RBA-1 cells by anticardiolipin antibodies was dose dependent and greater than that by human y globulin. Kinetic studies showed that anticardiolipin antibodies (100 [ig/ ml) inhibited the proliferation of RBA-1 cells (20 6 (5F1)% of the control) maximally after 24 hours of interaction whereas human y globulin had no significant effect on these cells (fig 2) . EFFECT is glial fibrillary acidic protein in the cytoplasm.
To determine if anticardiolipin antibodies interfere with the expression of glial fibrillary acidic protein, the immunofluorescence staining of glial fibrillary acidic protein in RBA-1 cells was evaluated after two days of incubation with < 0*001 anticardiolipin antibodies or y globulin. Binding ofRBA-1 cells with anticardiolipin antibodies (100 pglml) and human y globulin (100 pglml) Percentage 5) . In another experiment, the binding of anticardiolipin antibodies (100 ,tg/ml) or y globulin (100 jig/ml) with RBA-1 cells was measured by flow cytometry. The table shows that the percentage binding of RBA-1 with anticardiolipin antibodies was higher than that with y globulin.
IMMUNOFLUORESCENCE STAINING OF MOUSE BRAIN BY ANTICARDIOLIPIN ANTIBODIES AND ANTIBODIES TO GLIAL FIBRILLARY ACIDIC PROTEIN
As brain tissue contains many phospholipids, immunofluorescence staining of BALB/c mouse brain sections with anticardiolipin antibodies was carried out to see whether anticardiolipin antibodies are capable of binding with these phospholipid epitopes. Figure 6 shows that positive immunofluorescence staining of mouse brain by anticardiolipin antibodies was seen in the corpus callosum, a cellular zone near the corpus callosum, and nerve cells scattered in other portions of the brain. In contrast, negligible fluorescence was found in the stain with human y globulin (fig 7) . In the immunofluorescence staining of glial fibrillary acidic protein, positive results were also found in the corpus callosum and other areas of the brain (data not shown). In contrast, cryosections of mouse liver were not stained by anticardiolipin antibodies or antibodies to glial fibrillary acidic protein (data not shown) with the same method, indicating the high affinity of anticardiolipin antibodies with the brain tissue.
Discussion
Anticardiolipin antibodies are found in 22-70% of patients with SLE with neurological disorders,'0 including focal cerebral and ocular ischaemia, transverse myelopathy, peripheral neuropathy, and movement and seizure disorders. In most instances these disorders are thought to be the result of thrombosis or vasculopathy induced by immune complexes.' 2 12-15 Several workers have shown, however, that membrane reactive autoantibodies such as antineuronal antibodies are correlated with neuropsychiatric disorders of SLE.
Bluestein et a!27 and Minota et a!2" found that integrins and heat shock proteins (hsp9O) were potentially important membrane target mol- In addition to these observations there is some evidence that anticardiolipin antibodies also react with many types of activated cells in cell membranes. Khamashta et a129 showed that purified anticardiolipin antibodies bound to phosphatidylethanolamine, phosphatidylserine, and phosphatidylinositol epitopes expressed on the freeze thawed platelets and red blood cells. Schorer et al30 found that liposome purified anticardiolipin antibodies selectively inhibited prostacyclin release from thrombin activated endothelial cells. Misra et a12' and Yu et a122 showed that affinity purified anticardiolipin antibodies suppressed the proliferation of phytohaemagglutinin activated peripheral lymphocytes and phagocytosis of neutrophils. Dostal-Johnson et al3' found that serum samples from patients with lupus anticoagulant contained antibodies against phosphatidylserine, cardiolipin, phosphatidylinositol, phosphatidylglycerol, and phosphatidylethanolamine. Brain tissue contains a high proportion of phospholipids and may become the target of anticardiolipin antibodies, especially in patients with SLE.
It is possible that the blood-brain barrier is constructed by microvascular endothelial cells and astrocytes. 32 Functionally, this structure prohibits noxious substances such as autoantibodies from entering brain tissue. Although Lolli et al"9 found that the local synthesis of anticardiolipin antibodies within the central nervous system was possible in patients with multiple sclerosis, neurosyphilis, or Guillain-Barre syndrome, a simultaneous occurrence of anticardiolipin antibodies in the cerebrospinal fluid and serum of patients with SLE suggests that anticardiolipin antibodies may diffuse from serum to the central nervous system through a damaged blood-brain barrier. 33 In an attempt to further understand the pathological part played by anticardiolipin antibodies on the central nervous system lesions of SLE, normal rat astrocytes were used as target cells. We showed that micelle purified anticardiolipin antibodies in serum samples from patients with SLE exerted suppressive effects on these cells in a dose dependent manner. This observation has not been reported elsewhere. The inhibitory effect of anticardiolipin antibodies on normal rat brain astrocytes is important as about 75% of patients with neuropsychiatric SLE have blood-brain barrier damage.34 When RBA-I cells were incubated with anticardiolipin antibodies, the astrocytes became spherical in appearance and the cell membrane depolarised. It appears that anticardiolipin antibodies derange the structure and function of the blood-brain barrier, probably through their membrane effect.2' Once the blood-brain barrier is damaged, noxious substances, including cytotoxic antibodies, can access the brain tissue causing neuropsychiatric disorders. -In addition, direct binding of anticardiolipin antibodies to the cell membranes of RBA-1 cells, though only slight (table), was also seen in this study. This binding may interfere with the signal transduction of the cells. The epitope(s) on the surface membrane of RBA-1 cells for anticardiolipin antibody binding and the real mechanism for the interference of signal transduction after autoantibody binding were not investigated in this work.
Another interesting observation in this study is that anticardiolipin antibodies bound to brain tissue but not to liver tissue. It seems that anticardiolipin antibodies selectively attack brain tissue and elicit neuropsychiatric lesions in SLE in addition to non-specific thrombus formation in the blood vessels. The tissue specific property of other autoantibodies in SLE has been shown by the selective renal damage caused by antibodies to double stranded DNA. 36 Although we did not identify the target cells of the anticardiolipin antibodies in the brain, we noted that the nerve fibres and possibly glial cells in the corpus callosum, nerve cells in the cellular zone near the corpus callosum, and sporadic nerve cells in other brain areas were all positively stained by anticardiolipin antibodies (fig 6) . Whether anticardiolipin antibodies cross react with antineuronal, antilymphocyte, antiglycolipid, or antineurofilament antibodies needs further investigation.
In conclusion, we found that anticardiolipin antibodies exerted inhibitory effects on normal rat astrocytes (blood-brain barrier damage) and bound directly to nerve fibres and nerve cells in the brain. This dual effect of anticardiolipin antibodies leads us to suggest that anticardiolipin antibodies as autoantibodies to neural membranes play an important part in the pathogenesis of neuropsychiatric SLE.
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